Lebovits Chaim has filed 26 insider transactions across 1 company since March 2024.
Most recent transaction: a grant/award of 120000 shares of BRAINSTORM CELL THERAPEUTICS INC. ($BCLI) on January 01, 2025.
Activity breakdown: 13 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 1, 2025 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | Lebovits Chaim | President & CEO | A | Common Stock | 120000 | $0.00 | 334,349.0000 | 5,021,798 | 55.98% | 2.39% |
| Sept. 30, 2024 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | Lebovits Chaim | President & CEO | P | Common Stock | 22000 | $0.23 | 1,320,254.0000 | 4,747,699 | 1.69% | 0.46% |
| Oct. 1, 2024 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | Lebovits Chaim | President & CEO | P | Common Stock | 1836 | $3.43 | 214,349.0000 | 5,309,796 | 0.86% | 0.03% |
| May 22, 2024 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | Lebovits Chaim | President & CEO | P | Common Stock | 25000 | $0.64 | 3,150,712.0000 | 4,315,903 | 0.80% | 0.58% |
| May 10, 2024 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | Lebovits Chaim | President & CEO | P | Common Stock | 20000 | $0.47 | 3,080,712.0000 | 4,315,903 | 0.65% | 0.46% |
| May 11, 2024 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | Lebovits Chaim | President & CEO | P | Common Stock | 10000 | $0.47 | 3,090,712.0000 | 4,315,903 | 0.32% | 0.23% |
| May 13, 2024 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | Lebovits Chaim | President & CEO | P | Common Stock | 10000 | $0.49 | 3,100,712.0000 | 4,315,903 | 0.32% | 0.23% |
| May 7, 2024 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | Lebovits Chaim | President & CEO | P | Common Stock | 66300 | $0.37 | 3,060,712.0000 | 4,315,903 | 2.21% | 1.54% |
| May 6, 2024 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | Lebovits Chaim | President & CEO | P | Common Stock | 135000 | $0.38 | 2,994,412.0000 | 4,315,903 | 4.72% | 3.13% |
| April 19, 2024 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | Lebovits Chaim | President & CEO | P | Common Stock | 15000 | $0.52 | 2,859,412.0000 | 4,315,903 | 0.53% | 0.35% |
| April 17, 2024 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | Lebovits Chaim | President & CEO | P | Common Stock | 130000 | $0.55 | 2,729,340.0000 | 4,315,903 | 5.00% | 3.01% |
| May 28, 2024 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | Lebovits Chaim | President & CEO | P | Common Stock | 15000 | $0.52 | 3,165,712.0000 | 4,315,903 | 0.48% | 0.35% |
| May 21, 2024 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | Lebovits Chaim | President & CEO | P | Common Stock | 25000 | $0.58 | 3,125,712.0000 | 4,315,903 | 0.81% | 0.58% |
| April 18, 2024 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | Lebovits Chaim | President & CEO | P | Common Stock | 115072 | $0.53 | 2,844,412.0000 | 4,315,903 | 4.22% | 2.67% |
| May 28, 2024 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | Lebovits Chaim | President & CEO | A | Common Stock | 15000 | $0.52 | 3,165,712.0000 | 4,315,903 | 0.48% | 0.35% |
| May 21, 2024 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | Lebovits Chaim | President & CEO | A | Common Stock | 25000 | $0.58 | 3,125,712.0000 | 4,315,903 | 0.81% | 0.58% |
| May 22, 2024 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | Lebovits Chaim | President & CEO | A | Common Stock | 25000 | $0.64 | 3,150,712.0000 | 4,315,903 | 0.80% | 0.58% |
| May 13, 2024 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | Lebovits Chaim | President & CEO | A | Common Stock | 10000 | $0.49 | 3,100,712.0000 | 4,315,903 | 0.32% | 0.23% |
| May 10, 2024 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | Lebovits Chaim | President & CEO | A | Common Stock | 20000 | $0.47 | 3,080,712.0000 | 4,315,903 | 0.65% | 0.46% |
| May 11, 2024 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | Lebovits Chaim | President & CEO | A | Common Stock | 10000 | $0.47 | 3,090,712.0000 | 4,315,903 | 0.32% | 0.23% |
| May 6, 2024 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | Lebovits Chaim | President & CEO | A | Common Stock | 135000 | $0.38 | 2,994,412.0000 | 4,315,903 | 4.72% | 3.13% |
| May 7, 2024 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | Lebovits Chaim | President & CEO | A | Common Stock | 66300 | $0.37 | 3,060,712.0000 | 4,315,903 | 2.21% | 1.54% |
| April 19, 2024 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | Lebovits Chaim | President & CEO | A | Common Stock | 15000 | $0.52 | 2,859,412.0000 | 4,315,903 | 0.53% | 0.35% |
| April 18, 2024 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | Lebovits Chaim | President & CEO | A | Common Stock | 115072 | $0.53 | 2,844,412.0000 | 4,315,903 | 4.22% | 2.67% |
| April 17, 2024 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | Lebovits Chaim | President & CEO | A | Common Stock | 130000 | $0.55 | 2,729,340.0000 | 4,315,903 | 5.00% | 3.01% |
| March 11, 2024 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | Lebovits Chaim | President & CEO | A | Common Stock | 305198 | $0.00 | 2,599,340.0000 | 2,871,729 | 13.30% | 10.63% |